About
Sir Philip Cohen is a British biochemist at the University of Dundee whose research focuses on protein phosphorylation, ubiquitylation, and innate immune signalling. He helped establish the Division of Signal Transduction Therapy and has been influential in translating Dundee life-sciences research into industry collaborations and commercialisation efforts. He also serves in scientific advisory and trustee roles, including at Mission Therapeutics and The Tricia Cohen Memorial Trust.
Areas of interest
biochemistrycell signalingprotein phosphorylationubiquitylationinnate immunityinflammationinfectious diseasedrug discoverybiotechnology commercializationhigher educationscientific philanthropy